Sabby Management’s China SXT Pharmaceuticals SXTC Stock Holding History

Sabby Management’s Portfolio SXTC Stock Details SXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-977	Closed	-$131K	–	35
2026 Q1	$131K	Buy	+977	New	+$2.01M	0.29%	21

Other funds holding SXTC

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Sabby Management's SXTC Position: Q2 2026 in Review

Sabby Management sold out of China SXT Pharmaceuticals (SXTC) in Q2 2026, closing a stake of 977 shares — an estimated $131K sold.

Sabby Management first reported a position in SXTC in Q1 2026 and held it in 1 quarter. The position peaked at $131K in Q1 2026. 0 funds tracked by Wall St. Rank hold SXTC as of Q2 2026.

Sabby Management reported no remaining China SXT Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Sabby Management sold 977 China SXT Pharmaceuticals shares in Q2 2026, an estimated $131K.
Sabby Management first reported a position in China SXT Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Sabby Management's China SXT Pharmaceuticals position peaked at $131K in Q1 2026.
0 funds tracked by Wall St. Rank held China SXT Pharmaceuticals as of Q2 2026.

Based on Sabby Management's 13F filing for Q2 2026, filed 14 Aug 2026.